A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion

PLoS Pathogens

Volumn 9, Issue 4, 2013, Pages

  Vigant, Frederic ^a   Lee, Jihye ^a   Hollmann, Axel ^b   Tanner, Lukas B ^c,d   Akyol Ataman, Zeynep ^a   Yun, Tatyana ^e   Shui, Guanghou ^f,m   Aguilar, Hector C ^g   Zhang, Dong ^h   Meriwether, David ^a   Roman Sosa, Gleyder ^i,n   Robinson, Lindsey R ^a   Juelich, Terry L ^e   Buczkowski, Hubert ^j   Chou, Sunwen ^k   Castanho, Miguel A R B ^b   Wolf, Mike C ^a,o   Smith, Jennifer K ^e   Banyard, Ashley ^j   Kielian, Margaret ⁱ   Reddy, Srinivasa ^a   Wenk, Markus R ^c,f,l   Selke, Matthias ^h   Santos, Nuno C ^b   Freiberg, Alexander N ^e   Jung, Michael E ^a   Lee, Benhur ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e University of Texas Medical Branch School of Medicine   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g WASHINGTON STATE UNIVERSITY   (United States)

^h CALIFORNIA STATE UNIVERSITY   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j VETERINARY LABORATORIES AGENCY   (United Kingdom)

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^m INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

ⁿ UNIVERSITY OF ULM   (Germany)

^o DEFENSE THREAT REDUCTION AGENCY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; JL103; LJ001; PHOTOSENSITIZING AGENT; SINGLET OXYGEN; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANISOTROPY; ANTIVIRAL ACTIVITY; ARTICLE; CELL FUSION; CELL MEMBRANE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; FLUORESCENCE SPECTROSCOPY; INFLUENZA VIRUS A; LIGHT; LIPID OXIDATION; LIPIDOMICS; NONHUMAN; PARTITION COEFFICIENT; RIFT VALLEY FEVER BUNYAVIRUS; SEMLIKI FOREST ALPHAVIRUS; STRUCTURE ACTIVITY RELATION; VIROLOGY; VIRUS;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; CELL MEMBRANE; MICE; MICE, INBRED BALB C; OXAZOLES; PHOSPHOLIPIDS; PHOTOSENSITIZING AGENTS; RHODANINE; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SINGLET OXYGEN; STRUCTURE-ACTIVITY RELATIONSHIP; THIONES; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

MURINAE; RIFT VALLEY FEVER VIRUS;

EID: 84876852255     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003297     Document Type: Article

References (56)

1. De Clercq E, (2004) Antivirals and antiviral strategies. Nat Rev Microbiol 2: 704-720.
2. Zasloff M, Adams AP, Beckerman B, Campbell A, Han Z, et al. (2011) Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proc Natl Acad Sci U S A 108: 15978-15983.
3. Kesel AJ, (2011) Broad-spectrum antiviral activity including human immunodeficiency and hepatitis C viruses mediated by a novel retinoid thiosemicarbazone derivative. Eur J Med Chem 46: 1656-1664.
4. Wolf MC, Freiberg AN, Zhang T, Akyol-Ataman Z, Grock A, et al. (2010) A broad-spectrum antiviral targeting entry of enveloped viruses. Proc Natl Acad Sci U S A 107: 3157-3162.
5. St Vincent MR, Colpitts CC, Ustinov AV, Muqadas M, Joyce MA, et al. (2010) Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses. Proc Natl Acad Sci U S A 107: 17339-17344.
6. Boriskin YS, Leneva IA, Pecheur EI, Polyak SJ, (2008) Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Curr Med Chem 15: 997-1005.
7. Rider TH, Zook CE, Boettcher TL, Wick ST, Pancoast JS, et al. (2011) Broad-spectrum antiviral therapeutics. PLoS One 6: e22572.
8. Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML, (2011) Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci U S A 108: 5777-5782.
9. Bonavia A, Franti M, Pusateri Keaney E, Kuhen K, Seepersaud M, et al. (2011) Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV). Proc Natl Acad Sci U S A 108: 6739-6744.
10. Zhang L, Das P, Schmolke M, Manicassamy B, Wang Y, et al. (2012) Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export. J Cell Biol 196: 315-326.
11. Wilen CB, Tilton JC, Doms RW, (2012) Molecular mechanisms of HIV entry. Adv Exp Med Biol 726: 223-242.
12. Aguilar HC, Aspericueta V, Robinson LR, Aanensen KE, Lee B, (2010) A quantitative and kinetic fusion protein-triggering assay can discern distinct steps in the nipah virus membrane fusion cascade. J Virol 84: 8033-8041.
13. White JM, Delos SE, Brecher M, Schornberg K, (2008) Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 43: 189-219.
14. Sanchez-San Martin C, Liu CY, Kielian M, (2009) Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol 17: 514-521.
15. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, et al. (2006) The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A 103: 2641-2646.
16. Chan R, Uchil PD, Jin J, Shui G, Ott DE, et al. (2008) Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J Virol 82: 11228-11238.
17. Gerl MJ, Sampaio JL, Urban S, Kalvodova L, Verbavatz JM, et al. (2012) Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. J Cell Biol 196: 213-221.
18. Foote CS, Shook FC, Abakerli RB, (1984) Characterization of singlet oxygen. Methods Enzymol 105: 36-47.
19. Plaetzer K, Krammer B, Berlanda J, Berr F, Kiesslich T, (2009) Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci 24: 259-268.
20. Ayuyan AG, Cohen FS, (2006) Lipid peroxides promote large rafts: effects of excitation of probes in fluorescence microscopy and electrochemical reactions during vesicle formation. Biophys J 91: 2172-2183.
21. Girotti AW, (2008) Translocation as a means of disseminating lipid hydroperoxide-induced oxidative damage and effector action. Free Radic Biol Med 44: 956-968.
22. North J, Neyndorff H, Levy JG, (1993) Photosensitizers as virucidal agents. J Photochem Photobiol B 17: 99-108.
23. Sanford KW, Balogun RA, (2012) Extracorporeal photopheresis: Clinical use so far. J Clin Apher 27: 126-31.
24. Bernstein ZP, Dougherty T, Gollnick S, Schwartz SA, Mahajan SD, et al. (2008) Photopheresis in HIV-1 infected patients utilizing benzoporphyrin derivative (BPD) verteporfin and light. Curr HIV Res 6: 152-163.
25. Solheim BG, (2008) Pathogen reduction of blood components. Transfus Apher Sci 39: 75-82.
26. Costa L, Faustino MAF, Neves MGPMS, Cunha A, Almeida A, (2012) Photodynamic incativation of mammalian viruses and bacteriophages. Viruses pp. 1034-1074.
27. Lenard J, Rabson A, Vanderoef R, (1993) Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc Natl Acad Sci U S A 90: 158-162.
28. Hirayama J, Ikebuchi K, Abe H, Kwon KW, Ohnishi Y, et al. (1997) Photoinactivation of virus infectivity by hypocrellin A. Photochem Photobiol 66: 697-700.
29. Moor AC, Wagenaars-van Gompel AE, Brand A, Dubbelman MA, VanSteveninck J, (1997) Primary targets for photoinactivation of vesicular stomatitis virus by AIPcS4 or Pc4 and red light. Photochem Photobiol 65: 465-470.
30. Floyd RA, Schneider JE Jr, Dittmer DP, (2004) Methylene blue photoinactivation of RNA viruses. Antiviral Res 61: 141-151.
31. Kubin A, Wierrani F, Burner U, Alth G, Grunberger W, (2005) Hypericin-the facts about a controversial agent. Curr Pharm Des 11: 233-253.
32. Wang F, Han Y, Lim CS, Lu Y, Wang J, et al. (2010) Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 463: 1061-1065.
33. Wang F, Deng R, Wang J, Wang Q, Han Y, et al. (2011) Tuning upconversion through energy migration in core'Äìshell nanoparticles. Nat Mater 10: 968-973.
34. Idris NM, Gnanasammandhan MK, Zhang J, Ho PC, Mahendran R, et al. (2012) In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med 18: 1580-1585.
35. Chernomordik LV, Vogel SS, Sokoloff A, Onaran HO, Leikina EA, et al. (1993) Lysolipids reversibly inhibit Ca(2+)-, GTP- and pH-dependent fusion of biological membranes. FEBS Lett 318: 71-76.
36. Vigant F, Jung M, Lee B, (2010) Positive reinforcement for viruses. Chem Biol 17: 1049-1051.
37. Melikyan GB, (2010) Driving a wedge between viral lipids blocks infection. Proc Natl Acad Sci U S A 107: 17069-17070.
38. Krishnamoorthy G, Webb SP, Nguyen T, Chowdhury PK, Halder M, et al. (2005) Synthesis of hydroxy and methoxy perylene quinones, their spectroscopic and computational characterization, and their antiviral activity. Photochem Photobiol 81: 924-933.
39. Kubista M, (1994) Experimental correction for the inner-filter effect in fluorescence spectra. Analyst 119: 417-419.
40. Ladokhin AS, Jayasinghe S, White SH, (2000) How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal Biochem 285: 235-245.
41. Santos NC, Prieto M, Castanho MA, (2003) Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods. Biochim Biophys Acta 1612: 123-135.
42. Matos PM, Franquelim HG, Castanho MA, Santos NC, (2010) Quantitative assessment of peptide-lipid interactions. Ubiquitous fluorescence methodologies. Biochim Biophys Acta 1798: 1999-2012.
43. Chiu SW, Subramaniam S, Jakobsson E, (1999) Simulation study of a gramicidin/lipid bilayer system in excess water and lipid. II. Rates and mechanisms of water transport. Biophys J 76: 1939-1950.
44. Franquelim HG, Loura LM, Santos NC, Castanho MA, (2008) Sifuvirtide screens rigid membrane surfaces. establishment of a correlation between efficacy and membrane domain selectivity among HIV fusion inhibitor peptides. J Am Chem Soc 130: 6215-6223.
45. Veiga S, Henriques S, Santos NC, Castanho M, (2004) Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level. Biochem J 377: 107-110.
46. Vieira CR, Castanho M, Saldanha C, Santos NC, (2008) Enfuvirtide effects on human erythrocytes and lymphocytes functional properties. J Pept Sci 14: 448-454.
47. Lai SW, Liu Y, Zhang D, Wang B, Lok CN, et al. (2010) Efficient singlet oxygen generation by luminescent 2-(2′-thienyl)pyridyl cyclometalated platinum(II) complexes and their calixarene derivatives. Photochem Photobiol 86: 1414-1420.
48. Meriwether D, Imaizumi S, Grijalva V, Hough G, Vakili L, et al. (2011) Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma. J Lipid Res 52: 1795-1809.
49. Shui G, Stebbins JW, Lam BD, Cheong WF, Lam SM, et al. (2011) Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys? PLoS One 6: e19731.
50. Davis B, Koster G, Douet LJ, Scigelova M, Woffendin G, et al. (2008) Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein. J Biol Chem 283: 6428-6437.
51. Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, et al. (2006) N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol 80: 4878-4889.
52. Liao M, Kielian M, (2005) Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J Cell Biol 171: 111-120.
53. Lehrer SS, (1971) Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry 10: 3254-3263.
54. Nagle JF, Wiener MC, (1988) Structure of fully hydrated bilayer dispersions. Biochim Biophys Acta 942: 1-10.
55. Santos NC, Prieto M, Castanho MA, (1998) Interaction of the major epitope region of HIV protein gp41 with membrane model systems. A fluorescence spectroscopy study. Biochemistry 37: 8674-8682.
56. Chernomordik LV, Kozlov MM, (2008) Mechanics of membrane fusion. Nat Struct Mol Biol 15: 675-683.